Results 51 to 60 of about 775,328 (297)

Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment [PDF]

, 2016
With contemporary therapeutic strategies in multiple myeloma, heretofore unseen depth and rate of responses are being achieved. These strategies have paralleled improvements in outcome of multiple myeloma patients.
Jinming Song, Kenneth H. Shain, Taiga Nishihori   +2 more
core   +1 more source

Dynamics of Minimal Residual Disease in Neuroblastoma Patients

Frontiers in Oncology, 2019
Neuroblastoma is a common extracranial solid tumor of neural crest (NC) origin that accounts for up to 15% of all pediatric cancer deaths. The disease arises from a transient population of NC cells that undergo an epithelial-mesenchymal transition (EMT ...
Suguru Uemura, Toshiaki Ishida, Khin Kyae Mon Thwin, Nobuyuki Yamamoto, Akihiro Tamura, Kenji Kishimoto, Daiichiro Hasegawa, Yoshiyuki Kosaka, Nanako Nino, Kyaw San Lin, Satoru Takafuji, Takeshi Mori, Kazumoto Iijima, Noriyuki Nishimura   +13 more
doaj   +1 more source

FLT3 Length Mutations as Marker for Follow-Up Studies in Acute Myeloid Leukaemia [PDF]

, 2004
Length mutations within the FLT3 gene (FLT3-LM) can be found in 23% of acute myeloid leukaemia (AML) and thus are the most frequent mutations in AML. FLT3-LM are highly correlated with AML with normal karyotype and other cytogenetic aberrations of the ...
Haferlach, Torsten, Hiddemann, Wolfgang, Kern, Wolfgang, Schnittger, Susanne, Schoch, Claudia   +4 more
core   +1 more source

Metabolic memory underlying minimal residual disease in breast cancer

Molecular Systems Biology, 2021
Tumor relapse from treatment‐resistant cells (minimal residual disease, MRD) underlies most breast cancer‐related deaths. Yet, the molecular characteristics defining their malignancy have largely remained elusive.
Ksenija Radic Shechter, Eleni Kafkia, Katharina Zirngibl, Sylwia Gawrzak, Ashna Alladin, Daniel Machado, Christian Lüchtenborg, Daniel C Sévin, Britta Brügger, Kiran R Patil, Martin Jechlinger   +10 more
doaj   +1 more source

A Case Report of Acute Transverse Myelitis Following Novel Coronavirus Infection [PDF]

, 2020
Introduction: During the coronavirus disease 2019 (COVID-19) pandemic, emergency providers are not only seeing an increasing number of patients with COVID-19 infections, but also associated complications and sequelae of this viral illness.Case Report: We
Bilello, Leslie A., Sarma, Deesha
core  

Laparoscopic partial adrenalectomy for bilateral pheochromocytomas in a boy with von Hippel-Lindau disease [PDF]

, 2000
Objectives: In adults, increasing numbers of adrenalectomies for pheochromocytomas are performed laparoscopically. We report for the first time laparoscopic bilateral subtotal adrenalectomy for pheochromocytomas in an 8-year-old boy with von Hippel ...
Bartsch, Georg, Elsner, Romy, Janetschek, Günter, Neumann, Hartmut, Radmayr, Christian   +4 more
core   +1 more source

Review of precision cancer medicine: Evolution of the treatment paradigm. [PDF]

, 2020
In recent years, biotechnological breakthroughs have led to identification of complex and unique biologic features associated with carcinogenesis. Tumor and cell-free DNA profiling, immune markers, and proteomic and RNA analyses are used to identify ...
Fountzilas, Elena, Kurzrock, Razelle, Nikanjam, Mina, Tsimberidou, Apostolia M   +3 more
core   +1 more source

Cancer Special Issue: Early detection and minimal residual disease.

PLoS Medicine, 2021
Beryne Odeny discusses PLOS Medicine's Special Issue on early cancer detection and minimal residual disease.
Beryne Odeny
doaj   +1 more source

EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical endpoint for multiple myeloma.

Blood
Estimating progression-free survival (PFS) and overall survival (OS) superiority during clinical trials of multiple myeloma (MM) has become increasingly challenging as novel therapeutics have improved patient outcomes.
O. Landgren, Thomas J. Prior, T. Masterson, Christoph Heuck, Orlando F Bueno, Ajeeta B. Dash, H. Einsele, H. Goldschmidt, Stefan Knop, Cong Li, U. Mellqvist, I. McFadden, Corina Oprea, Jeremy A. Ross, Mihaela Talpes, Jay R. Hydren, Jenny Ahlstrom, D. Kazandjian, Niels Weinhold, Rick Zhang, M. Stetler-Stevenson, Gerald E. Marti, Sean M. Devlin   +22 more
semanticscholar   +1 more source

Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysis [PDF]

, 2017
We analyzed 50 patients who achieved at least a very good partial response in the RV-MM-EMN-441 study. Patients received consolidation with autologous stem-cell transplantation (ASCT) or cyclophosphamide-lenalidomide-dexamethasone (CRD), followed by ...
Bernardini, A, Boccadoro, M, Caravita, T, Conticello, C, Drandi, D, Ferrero, S, Gambella, M, Gay, F, Genuardi, M, Gilestro, M, Liberati, Am, Muccio, Ve, Musto, P, Oliva, S, Omed\ue8, P., Palumbo, A, Passera, R, Patriarca, Francesca, Pautasso, C, Pescosta, N, Petrucci, Mt, Rocci, A, Saraci, E   +22 more
core   +2 more sources